Expanding Access to Patients in Need Around the World

Interview with Gregg H. Alton, Ph.D., Executive VP, Corporate and Medical Affairs, Gilead Sciences, Inc.
Part 3: Activities in Asia

226 views

Share:

00:03:40 - Uploaded by Essinova on June 20, 2010

(Subtitled in Chinese. Translation by Charles Liu, Ph.D., Gilead Sciences; member of CABS)

At BioPacific2010, Gregg Alton spoke to Essinova host, BeiBei Song about Gilead's HIV/AIDS product portfolio, the company's pipeline status, its global access program and initiatives in Asia.

Tags: CABS, BioPacific 2010, Gregg Alton, Gilead, HIV, AIDS, Viread, Truvada, Atripla, hepatitis C

RELATED

COMMENTS

There are 0 comments. You must be logged in to comment.

Discovery & Development

 photo Essinova-Brain-and-Mind-banner_iStock_000004422514Medium.jpg

 photo Essinova_Art-and-Science-banner_PIA09962.jpg